Literature DB >> 2817835

Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection.

R S Janssen1, A J Saykin, L Cannon, J Campbell, P F Pinsky, N A Hessol, P M O'Malley, A R Lifson, L S Doll, G W Rutherford.   

Abstract

To determine whether neurological and neuropsychological abnormalities are associated with clinical manifestations of human immunodeficiency virus type 1 (HIV-1) infection in men who do not have acquired immunodeficiency syndrome (AIDS), we performed a historical prospective and cross-sectional study. One hundred HIV-1 seropositive homosexual or bisexual men, of whom 26 had AIDS-related complex, 31 had generalized lymphadenopathy, and 43 had no signs or symptoms of HIV-1 infection, and 157 HIV-1 seronegative men were enrolled from a cohort of 6,701 men who were originally recruited between 1978 and 1980 for studies of hepatitis B virus infection. Evaluation included medical history, physical examination, and neuropsychological tests. Of 26 HIV-1 seropositive subjects with AIDS-related complex, 11 (42%) reported neurological, cognitive, or affective symptoms compared with 30 (19%) of 157 HIV-1 seronegative subjects (relative risk = 2.2, p = 0.02). On neuropsychological testing, subjects with AIDS-related complex performed at a significantly lower level than the HIV-1 seronegative group (p = 0.001). A significantly higher percentage of subjects with AIDS-related complex (8[31%]of 26) than HIV-1 seronegative subjects (19 [12%] of 157) had abnormal results on two or more neuropsychological tests (rate ratio = 2.5, p = 0.03). Symptoms and impairment on neuropsychological tests were correlated only within the group who had AIDS-related complex. Subjects with generalized lymphadenopathy and subjects who had no signs or symptoms of HIV-1 infection were not different from HIV-1 seronegative subjects with respect to symptoms or performance on neuropsychological tests.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817835     DOI: 10.1002/ana.410260503

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 2.  Psychiatry.

Authors:  K Granville-Grossman
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 3.  Neuropsychiatric aspects of HIV infection.

Authors:  I P Everall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

4.  Electrophysiological motor testing, MRI findings and clinical course in AIDS patients with dementia.

Authors:  G Arendt; H Hefter; E Neuen-Jacob; S Wist; H Kuhlmann; G Strohmeyer; H J Freund
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

Review 5.  The pathogenesis of the neurological complications of HIV-1 infection.

Authors:  B J Brew
Journal:  Genitourin Med       Date:  1993-10

6.  Neurocognitive effects of HIV, hepatitis C, and substance use history.

Authors:  Kathryn N Devlin; Assawin Gongvatana; Uraina S Clark; Jesse D Chasman; Michelle L Westbrook; Karen T Tashima; Bradford Navia; Ronald A Cohen
Journal:  J Int Neuropsychol Soc       Date:  2011-12-02       Impact factor: 2.892

7.  An early increase in somatostatin mRNA expression in the frontal cortex of rhesus monkeys infected with simian immunodeficiency virus.

Authors:  A Da Cunha; D M Rausch; L E Eiden
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a.

Authors:  Davide Eletto; Giuseppe Russo; Giovanni Passiatore; Luis Del Valle; Antonio Giordano; Kamel Khalili; Elisa Gualco; Francesca Peruzzi
Journal:  J Cell Physiol       Date:  2008-09       Impact factor: 6.384

9.  HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers.

Authors:  H J von Giesen; H Hefter; H Roick; S Mauss; G Arendt
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

10.  Neurological and neuropsychological performance in HIV seropositive men without symptoms.

Authors:  R H McAllister; M V Herns; M J Harrison; S P Newman; S Connolly; C J Fowler; M Fell; P Durrance; H Manji; B E Kendall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.